comparison between the effect of two medicines used in psoriasis in different doses and combination.
Not Applicable
- Conditions
- Health Condition 1: null- chronic plaque psoriasis
- Registration Number
- CTRI/2018/07/015044
- Lead Sponsor
- IMS BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with chronic plaque psoriasis with
BSA > 10,
PASI >10
Exclusion Criteria
Pregnancy,lactation, child bearing age group in females, alcoholic, liver disorders, kidney disorders, Hemoglobin < 8 g/dl, TLC < 400O per microlitre, platelet <1 lakh per microlitre, immunosupression,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Achievement of PASI 75Timepoint: Followed every 2 weeks for 12 weeks
- Secondary Outcome Measures
Name Time Method Experience as of primary outcomeTimepoint: Followed every 2 weeks for 12 weeks